特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
531335

呼吸器系疾患治療薬の世界市場:将来予測

Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth

出版日: | 発行: The Business Research Company | ページ情報: 英文 | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.35円
呼吸器系疾患治療薬の世界市場:将来予測
出版日: 2020年05月19日
発行: The Business Research Company
ページ情報: 英文
納期: 2-3営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の呼吸器系疾患向け治療薬の市場構造・動向について分析し、市場の主な特徴・構造や、全体的な市場規模・成長率の動向見通し、種類別・地域別・主要国の詳細動向、主なマクロ経済指標との対比、主要企業のプロファイル、近年の市場の主な傾向などを調査しております。

第1章 エグゼクティブサマリー

第2章 分析構造

第3章 呼吸器系疾患治療薬市場の特徴

第4章 呼吸器系疾患治療薬市場:製品別の分析

  • 主要な製品/サービス
  • 主な機能と差別化要因
  • 開発中の製品

第5章 呼吸器系疾患治療薬市場のサプライチェーン

  • サプライチェーン
  • 流通
  • 最終顧客

第6章 呼吸器系疾患治療薬市場:顧客情報

  • 顧客側の選好
  • エンドユース市場の規模と成長率

第7章 呼吸器系疾患治療薬市場:動向と戦略

第8章 呼吸器系疾患治療薬:市場規模と成長率

  • 市場規模
  • 市場成長率:実績値 (金額ベース)
    • 市場促進要因
    • 市場抑制要因
  • 市場成長率:予測値 (金額ベース)
    • 市場促進要因
    • 市場抑制要因

第9章 呼吸器系疾患治療薬の市場:地域別の分析

  • 市場規模の最新値:地域別 (金額ベース、2018年)
  • 市場規模の実績値・予測値:地域別 (金額ベース、2014~2022年)
  • 成長率・市場シェアの比較:地域別

第10章 呼吸器系疾患治療薬の市場:セグメント別の分析

  • セグメント別の市場規模:実績値・予測値 (金額ベース、2014~2022年)
    • 抗喘息薬/COPD治療薬
    • 感冒薬

第11章 呼吸器系疾患治療薬の市場:主要指標

  • 市場規模の対GDP比 (全世界、2014~2022年)
  • 一人当たり平均支出額 (全世界、2014~2022年)

第12章 アジア太平洋地域の呼吸器系疾患治療薬の市場

  • 市場概要
  • 市場規模の最新値:国別 (金額ベース、2018年)
  • 市場規模の実績値・予測値:国別 (2014~2022年)
  • 市場成長率・市場シェア:国別比較 (2014~2022年)
  • 関連指標
    • 1人当たり支出額 (2014~2022年)
    • 喘息有病率 (2018年)
  • 市場規模:種類別 (金額ベース、2014~2022年)
  • 国別分析
    • 中国
    • オーストラリア
    • 香港
    • インド
    • インドネシア
    • 日本
    • マレーシア
    • ニュージーランド
    • フィリピン
    • シンガポール
    • 韓国
    • タイ
    • ベトナム

第13章 西欧の呼吸器系疾患治療薬の市場

  • 国別分析
    • オーストリア
    • ベルギー
    • デンマーク
    • フィンランド
    • フランス
    • ドイツ
    • アイルランド
    • イタリア
    • オランダ
    • ノルウェー
    • ポルトガル
    • スペイン
    • スウェーデン
    • スイス
    • 英国

第14章 東欧の呼吸器系疾患治療薬の市場

  • 国別分析
    • チェコ
    • ポーランド
    • ルーマニア
    • ロシア

第15章 北米の呼吸器系疾患治療薬の市場

  • 国別分析
    • カナダ
    • メキシコ
    • 米国

第16章 南米の呼吸器系疾患治療薬の市場

  • 国別分析
    • アルゼンチン
    • ブラジル
    • チリ
    • コロンビア
    • ペルー
    • ベネズエラ

第17章 中東の呼吸器系疾患治療薬の市場

  • 国別分析
    • サウジアラビア
    • イスラエル
    • トルコ
    • アラブ首長国連邦 (UAE)

第18章 アフリカの呼吸器系疾患治療薬の市場

  • 国別分析
    • エジプト
    • ナイジェリア
    • 南アフリカ

第19章 呼吸器系疾患治療薬市場の競合情勢

  • 競争市場概要
  • 市場シェア
  • 企業プロファイル
    • GlaxosmithKline Plc
    • AstraZeneca Plc
    • Merck & Co
    • Novartis AG
    • Johnson & Johnson
第20章 呼吸器系疾患治療薬市場における主な企業合併・買収 (M&A) 第21章 市場の背景事情:医薬品市場
  • 市場の特徴
  • 市場規模・成長率の推移と予測:分野別 (金額ベース、2014~2022年)
  • 市場規模:地域別 (金額ベース、2018年)
  • 市場規模:地域別 (2014~2022年)
  • 市場規模:種類別 (金額ベース、2014~2022年)
第22章 提言
  • 成長国向け提言
  • 成長分野向け提言
  • 成長戦略の提言
第23章 付録 第24章 著作権・免責事項
目次

‘Respiratory Diseases Drugs Global Market Report 2020-30: Covid 19 Implications and Growth ’ from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for respiratory diseases drugs which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the respiratory diseases drugs market? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Respiratory Diseases Drugs Market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider respiratory diseases drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The respiratory diseases drugs market section of the report gives context. It compares the respiratory diseases drugs market with other segments of the respiratory diseases drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, respiratory diseases drugs indicators comparison.

Scope

Markets Covered:

1) By Type: Anti-Asthmatics And COPD Drugs; Cough And Cold Preparations

2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others

3) By Route Of Administration: Oral; Parenteral; Others

4) By Drug Classification: Branded Drugs; Generic Drugs

5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: GlaxosmithKline Plc; AstraZeneca Plc; Merck & Co; Novartis AG; Johnson & Johnson

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, respiratory diseases drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Respiratory Diseases Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Respiratory Diseases Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Respiratory Diseases Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Respiratory Diseases Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Respiratory Diseases Drugs Market Trends And Strategies

8. Respiratory Diseases Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Respiratory Diseases Drugs Market Regional Analysis

  • 9.1. Global Respiratory Diseases Drugs Market, 2019, By Region, Value ($ Billion)
  • 9.2. Global Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 9.3. Global Respiratory Diseases Drugs Market, Growth And Market Share Comparison, By Region

10. Respiratory Diseases Drugs Market Segmentation

  • 10.1. Global Respiratory Diseases Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Anti-Asthmatics And COPD Drugs

Cough And Cold Preparations

  • 10.2. Global Respiratory Diseases Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Hospital Pharmacies

Retail Pharmacies/ Drug Stores

Others

  • 10.3. Global Respiratory Diseases Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Oral

Parenteral

Others

  • 10.4. Global Respiratory Diseases Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Branded Drugs

Generic Drugs

  • 10.5. Global Respiratory Diseases Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

Prescription-Based Drugs

Over-The-Counter Drugs

11. Respiratory Diseases Drugs Market Metrics

  • 11.1. Respiratory Diseases Drugs Market Size, Percentage Of GDP, 2015-2023, Global
  • 11.2. Per Capita Average Respiratory Diseases Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Respiratory Diseases Drugs Market

  • 12.1. Asia-Pacific Respiratory Diseases Drugs Market Overview
  • 12.2. Asia-Pacific, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Respiratory Diseases Drugs Market Metrics
    • 12.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Asia-Pacific Countries
    • 12.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Asia-Pacific Countries
  • 12.6. Asia-Pacific Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 12.7. Asia-Pacific Respiratory Diseases Drugs Market: Country Analysis
    • 12.7.1. China Respiratory Diseases Drugs Market
      • 12.7.1.1. China Respiratory Diseases Drugs Market Overview
      • 12.7.1.2. China Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.1.3. China Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.2. Australia Respiratory Diseases Drugs Market
      • 12.7.2.1. Australia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.2.2. Australia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.3. Hong Kong Respiratory Diseases Drugs Market
      • 12.7.3.1. Hong Kong Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.4. India Respiratory Diseases Drugs Market
      • 12.7.4.1. India Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.4.2. India Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.5. Indonesia Respiratory Diseases Drugs Market
      • 12.7.5.1. Indonesia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.5.2. Indonesia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.6. Japan Respiratory Diseases Drugs Market
      • 12.7.6.1. Japan Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.6.2. Japan Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.7. Malaysia Respiratory Diseases Drugs Market
      • 12.7.7.1. Malaysia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.8. New Zealand Respiratory Diseases Drugs Market
      • 12.7.8.1. New Zealand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.9. Philippines Respiratory Diseases Drugs Market
      • 12.7.9.1. Philippines Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.10. Singapore Respiratory Diseases Drugs Market
      • 12.7.10.1. Singapore Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.11. South Korea Respiratory Diseases Drugs Market
      • 12.7.11.1. South Korea Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 12.7.11.2. South Korea Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.12. Thailand Respiratory Diseases Drugs Market
      • 12.7.12.1. Thailand Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 12.7.13. Vietnam Respiratory Diseases Drugs Market
      • 12.7.13.1. Vietnam Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Respiratory Diseases Drugs Market

  • 13.1. Western Europe Respiratory Diseases Drugs Market Overview
  • 13.2. Western Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 13.3. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 13.4. Western Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Respiratory Diseases Drugs Market Metrics
    • 13.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Western Europe Countries
    • 13.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Western Europe Countries
  • 13.6. Western Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 13.7. Western Europe Respiratory Diseases Drugs Market: Country Analysis
    • 13.7.1. Austria Respiratory Diseases Drugs Market
      • 13.7.1.1. Austria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.2. Belgium Respiratory Diseases Drugs Market
      • 13.7.2.1. Belgium Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.3. Denmark Respiratory Diseases Drugs Market
      • 13.7.3.1. Denmark Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.4. Finland Respiratory Diseases Drugs Market
      • 13.7.4.1. Finland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.5. France Respiratory Diseases Drugs Market
      • 13.7.5.1. France Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.5.2. France Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.6. Germany Respiratory Diseases Drugs Market
      • 13.7.6.1. Germany Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.6.2. Germany Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.7. Ireland Respiratory Diseases Drugs Market
      • 13.7.7.1. Ireland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.8. Italy Respiratory Diseases Drugs Market
      • 13.7.8.1. Italy Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.9. Netherlands Respiratory Diseases Drugs Market
      • 13.7.9.1. Netherlands Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.10. Norway Respiratory Diseases Drugs Market
      • 13.7.10.1. Norway Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.11. Portugal Respiratory Diseases Drugs Market
      • 13.7.11.1. Portugal Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.12. Spain Respiratory Diseases Drugs Market
      • 13.7.12.1. Spain Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.13. Sweden Respiratory Diseases Drugs Market
      • 13.7.13.1. Sweden Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.14. Switzerland Respiratory Diseases Drugs Market
      • 13.7.14.1. Switzerland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 13.7.15. UK Respiratory Diseases Drugs Market
      • 13.7.15.1. UK Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 13.7.15.2. UK Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Respiratory Diseases Drugs Market

  • 14.1. Eastern Europe Respiratory Diseases Drugs Market Overview
  • 14.2. Eastern Europe, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Respiratory Diseases Drugs Market Metrics
    • 14.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Eastern Europe Countries
    • 14.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Eastern Europe Countries
  • 14.6. Eastern Europe Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 14.7. Eastern Europe Respiratory Diseases Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Respiratory Diseases Drugs Market,
      • 14.7.1.1. Czech Republic Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.2. Poland Respiratory Diseases Drugs Market
      • 14.7.2.1. Poland Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.3. Romania Respiratory Diseases Drugs Market
      • 14.7.3.1. Romania Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 14.7.4. Russia Respiratory Diseases Drugs Market
      • 14.7.4.1. Russia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 14.7.4.2. Russia Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Respiratory Diseases Drugs Market

  • 15.1. North America Respiratory Diseases Drugs Market Overview
  • 15.2. North America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 15.3. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 15.4. North America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 15.5. North America, Respiratory Diseases Drugs Market Metrics
    • 15.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, North America Countries
    • 15.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, North America Countries
  • 15.6. North America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 15.7. North America Respiratory Diseases Drugs Market: Country Analysis
    • 15.7.1. Canada Respiratory Diseases Drugs Market
      • 15.7.1.1. Canada Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.2. Mexico Respiratory Diseases Drugs Market
      • 15.7.2.1. Mexico Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 15.7.3. USA Respiratory Diseases Drugs Market
      • 15.7.3.1. USA Respiratory Diseases Drugs Market Overview
      • 15.7.3.2. USA Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 15.7.3.3. USA Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Respiratory Diseases Drugs Market

  • 16.1. South America Respiratory Diseases Drugs Market Overview
  • 16.2. South America, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 16.3. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 16.4. South America, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 16.5. South America, Respiratory Diseases Drugs Market Metrics
    • 16.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, South America Countries
    • 16.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, South America Countries
  • 16.6. South America Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 16.7. South America Respiratory Diseases Drugs Market: Country Analysis
    • 16.7.1. Argentina Respiratory Diseases Drugs Market
      • 16.7.1.1. Argentina Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.2. Brazil Respiratory Diseases Drugs Market
      • 16.7.1.1. Brazil Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
      • 16.7.2.2. Brazil Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.3. Chile Respiratory Diseases Drugs Market
      • 16.7.3.1. Chile Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.4. Colombia Respiratory Diseases Drugs Market
      • 16.7.4.1. Colombia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.5. Peru Respiratory Diseases Drugs Market
      • 16.7.5.1. Peru Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 16.7.6. Venezuela Respiratory Diseases Drugs Market
      • 16.7.6.1. Venezuela Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Respiratory Diseases Drugs Market

  • 17.1. Middle East Respiratory Diseases Drugs Market Overview
  • 17.2. Middle East, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 17.3. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 17.4. Middle East, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Respiratory Diseases Drugs Market Metrics
    • 17.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Middle East Countries
    • 17.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Middle East Countries
  • 17.6. Middle East Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 17.7. Middle East Respiratory Diseases Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Respiratory Diseases Drugs Market
      • 17.7.1.1. Saudi Arabia Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.2. Israel Respiratory Diseases Drugs Market
      • 17.7.2.1. Israel Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.3. Turkey Respiratory Diseases Drugs Market
      • 17.7.3.1. Turkey Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 17.7.4. UAE Respiratory Diseases Drugs Market
      • 17.7.4.1. UAE Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Respiratory Diseases Drugs Market

  • 18.1. Africa Respiratory Diseases Drugs Market Overview
  • 18.2. Africa, Respiratory Diseases Drugs Market, 2019, By Country, Value ($ Billion)
  • 18.3. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
  • 18.4. Africa, Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Respiratory Diseases Drugs Market Metrics
    • 18.5.1. Per Capita Average Respiratory Diseases Drugs Expenditure, 2015-2023, Africa Countries
    • 18.5.2. Asthma Prevalence Rate, Respiratory Diseases Drugs Market, Respiratory Diseases Drugs Market/Asthma Prevalence Rate, 2019, Africa Countries
  • 18.6. Africa Respiratory Diseases Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
  • 18.7. Africa Respiratory Diseases Drugs Market: Country Analysis
    • 18.7.1. Egypt Respiratory Diseases Drugs Market
      • 18.7.1.1. Egypt Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.2. Nigeria Respiratory Diseases Drugs Market
      • 18.7.2.1. Nigeria Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
    • 18.7.3. South Africa Respiratory Diseases Drugs Market
      • 18.7.3.1. South Africa Respiratory Diseases Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Respiratory Diseases Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. GlaxosmithKline Plc
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Products And Services
      • 19.3.1.3. Strategy
      • 19.3.1.4. Financial Performance
    • 19.3.2. AstraZeneca Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Products And Services
      • 19.3.2.3. Strategy
      • 19.3.2.4. Financial Performance
    • 19.3.3. Merck & Co
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Products And Services
      • 19.3.3.3. Strategy
      • 19.3.3.4. Financial Performance
    • 19.3.4. Novartis AG
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Products And Services
      • 19.3.4.3. Strategy
      • 19.3.4.4. Financial Performance
    • 19.3.5. Johnson & Johnson
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Products And Services
      • 19.3.5.3. Strategy
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Respiratory Diseases Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Respiratory Diseases Drugs Market In 2023- Growth Countries
  • 22.2. Global Respiratory Diseases Drugs Market In 2023- Growth Segments
  • 22.3. Global Respiratory Diseases Drugs Market In 2023- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.